NO991569D0 - Flytende alendronatforbindelser - Google Patents

Flytende alendronatforbindelser

Info

Publication number
NO991569D0
NO991569D0 NO991569A NO991569A NO991569D0 NO 991569 D0 NO991569 D0 NO 991569D0 NO 991569 A NO991569 A NO 991569A NO 991569 A NO991569 A NO 991569A NO 991569 D0 NO991569 D0 NO 991569D0
Authority
NO
Norway
Prior art keywords
compounds
liquid
liquid alendronate
alendronate compounds
alendronate
Prior art date
Application number
NO991569A
Other languages
English (en)
Other versions
NO991569L (no
Inventor
Maneesh J Nerurkar
William H Hunke
Drazen Ostovic
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700541.7A external-priority patent/GB9700541D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO991569D0 publication Critical patent/NO991569D0/no
Publication of NO991569L publication Critical patent/NO991569L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO991569A 1996-10-04 1999-03-30 Flytende alendronatforbindelser NO991569L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2676596P 1996-10-04 1996-10-04
GBGB9700541.7A GB9700541D0 (en) 1997-01-13 1997-01-13 Liquid alendronate formulation
US3600297P 1997-01-22 1997-01-22
PCT/US1997/015740 WO1998014196A1 (en) 1996-10-04 1997-10-02 Liquid alendronate formulations

Publications (2)

Publication Number Publication Date
NO991569D0 true NO991569D0 (no) 1999-03-30
NO991569L NO991569L (no) 1999-06-04

Family

ID=27268667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991569A NO991569L (no) 1996-10-04 1999-03-30 Flytende alendronatforbindelser

Country Status (20)

Country Link
EP (1) EP1007054A4 (no)
JP (1) JP2001501222A (no)
CN (1) CN1238691A (no)
AU (1) AU723357B2 (no)
BG (1) BG103306A (no)
BR (1) BR9712197A (no)
CA (1) CA2267370A1 (no)
CZ (1) CZ116999A3 (no)
EA (1) EA001213B1 (no)
EE (1) EE03669B1 (no)
HU (1) HUP0000125A3 (no)
IL (1) IL129127A0 (no)
IS (1) IS5012A (no)
NO (1) NO991569L (no)
NZ (1) NZ334836A (no)
PL (1) PL332496A1 (no)
SK (1) SK42999A3 (no)
TR (1) TR199900730T2 (no)
WO (1) WO1998014196A1 (no)
YU (1) YU17499A (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2243457T3 (es) * 2001-01-23 2005-12-01 Gador S.A. Composicion que comprende bifosfonatos para la prevencion y/o tratamiento de trastornos metabolicos de huesos, procedimiento de preparacion de dicha composicion y usos de la misma.
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7473684B2 (en) 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
AU2006290519B2 (en) * 2005-09-16 2012-10-18 Selamine Ltd Bisphosphonate formulation
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および／または治療のための組成物、その組成物の調製方法およびその使用
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206209A (en) * 1978-11-02 1980-06-03 Kracauer Paul Sublingual aspirin tablet
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5510517A (en) * 1993-08-25 1996-04-23 Merck & Co., Inc. Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy

Also Published As

Publication number Publication date
SK42999A3 (en) 2000-01-18
NO991569L (no) 1999-06-04
IS5012A (is) 1999-03-26
CN1238691A (zh) 1999-12-15
PL332496A1 (en) 1999-09-13
IL129127A0 (en) 2000-02-17
AU4644897A (en) 1998-04-24
EE03669B1 (et) 2002-04-15
YU17499A (en) 1999-11-22
EP1007054A4 (en) 2000-07-19
CZ116999A3 (cs) 1999-09-15
EE9900113A (et) 1999-10-15
BG103306A (en) 2000-01-31
HUP0000125A3 (en) 2001-04-28
WO1998014196A1 (en) 1998-04-09
TR199900730T2 (xx) 1999-07-21
EP1007054A1 (en) 2000-06-14
NZ334836A (en) 2000-11-24
CA2267370A1 (en) 1998-04-09
EA001213B1 (ru) 2000-12-25
JP2001501222A (ja) 2001-01-30
BR9712197A (pt) 1999-08-31
HUP0000125A2 (hu) 2000-06-28
EA199900352A1 (ru) 1999-08-26
AU723357B2 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
ID19609A (id) Senyawa-senyawa heterosiklik
ID19403A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
PT860428E (pt) Compostos pirimidiona
IS5479A (is) Efnasambönd
IS5478A (is) Efnasambönd
IS5477A (is) Efnasambönd
ID15904A (id) Senyawa-senyawa tiofenopirimidina
ID22850A (id) Senyawa-senyawa pirazina
DK0777671T3 (da) Spiro-azabicykliske forbindelser
NO994877D0 (no) Kalsilytiske forbindelser
BR9710352A (pt) Compostos piridilpirrole
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
ID20323A (id) Senyawa-senyawa triazinilaminostilbena
ID18685A (id) Senyawa trisiklik tersubstitusi
EE9900448A (et) Ühendid
BR9705635A (pt) Compostos
NO991569D0 (no) Flytende alendronatforbindelser
DK0923594T3 (da) Bromotiacumicinforbindelser
FI970151A (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
EE9900475A (et) Ühendid
ID20565A (id) Penuntun cairan-cairan secara terus-menerus
IS5323A (is) Efnasambönd
ID22983A (id) Senyawa-senyawa fluorometoksimino

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application